Vicente Anido, Jr.
2021
Compensation breakdown
Option Awards | $1,458,192 |
---|---|
Salary | $581,024 |
Stock Awards | $493,920 |
Other | $1,240,014 |
Total | $3,773,150 |
Anido received $1.5M in option awards, accounting for 39% of the total pay in 2021.
Anido also received $581K in salary, $493.9K in stock awards and $1.2M in other compensation.
Rankings
In 2021, Vicente Anido, Jr.'s compensation ranked 3,533rd out of 12,415 executives tracked by ExecPay. In other words, Anido earned more than 71.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,533 | 72nd |
Manufacturing | 1,449 | 74th |
Chemicals And Allied Products | 587 | 75th |
Drugs | 524 | 75th |
Biological Products, Except Diagnostic Substances | 137 | 70th |
Anido's colleagues
We found seven more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2021.
2021
Raj Kannan
Aerie Pharmaceuticals
Chief Executive Officer
2021
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
2021
Casey Kopczynski
Aerie Pharmaceuticals
Chief Innovation Officer, Head of Research and External Innovation
2021
John LaRocca
Aerie Pharmaceuticals
General Counsel
2021
Benjamin McGraw
Aerie Pharmaceuticals
Former Interim Executive Chair
2021
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
2021
Christopher Staten
Aerie Pharmaceuticals
Chief Financial Officer
News
April 26, 2022
April 27, 2021
April 24, 2020
April 10, 2019